ResearcherZhejiang Provincial People's HospitalActive in the last 2 years

Mou Yiping

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 8 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 1 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2025: 1 paper

Papers 1

Discovery of compound 1105486 as a selective inhibitor of B4GALT1: potential for pancreatic cancer therapy. First author DOI 10.3389/fchem.2025.1651402 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yunyun Xu · 1 shared paper, 2025 · strength 0.54
- Paper Discovery of compound 1105486 as a selective inhibitor of B4GALT1: potential for pancreatic cancer therapy. DOI 10.3389/fchem.2025.1651402 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.